Global Blood Therapeutics, Inc. Debt to Equity Ratio 2015-2022 | GBT
Current and historical debt to equity ratio values for Global Blood Therapeutics, Inc. (GBT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Global Blood Therapeutics, Inc. debt/equity for the three months ending June 30, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-06-30 |
$0.75B |
$0.12B |
6.35 |
2022-03-31 |
$0.74B |
$0.13B |
5.49 |
2021-12-31 |
$0.74B |
$0.20B |
3.78 |
2021-09-30 |
$0.30B |
$0.31B |
0.97 |
2021-06-30 |
$0.30B |
$0.32B |
0.95 |
2021-03-31 |
$0.29B |
$0.36B |
0.79 |
2020-12-31 |
$0.31B |
$0.42B |
0.74 |
2020-09-30 |
$0.23B |
$0.46B |
0.51 |
2020-06-30 |
$0.23B |
$0.50B |
0.46 |
2020-03-31 |
$0.22B |
$0.52B |
0.42 |
2019-12-31 |
$0.22B |
$0.58B |
0.38 |
2019-09-30 |
$0.07B |
$0.66B |
0.11 |
2019-06-30 |
$0.07B |
$0.70B |
0.09 |
2019-03-31 |
$0.06B |
$0.56B |
0.10 |
2018-12-31 |
$0.05B |
$0.57B |
0.08 |
2018-09-30 |
$0.04B |
$0.47B |
0.08 |
2018-06-30 |
$0.03B |
$0.51B |
0.07 |
2018-03-31 |
$0.04B |
$0.54B |
0.07 |
2017-12-31 |
$0.04B |
$0.32B |
0.12 |
2017-09-30 |
$0.03B |
$0.26B |
0.10 |
2017-06-30 |
$0.02B |
$0.28B |
0.07 |
2017-03-31 |
$0.02B |
$0.30B |
0.05 |
2016-12-31 |
$0.02B |
$0.19B |
0.09 |
2016-09-30 |
$0.01B |
$0.21B |
0.07 |
2016-06-30 |
$0.01B |
$0.22B |
0.07 |
2016-03-31 |
$0.01B |
$0.13B |
0.10 |
2015-12-31 |
$0.01B |
$0.14B |
0.08 |
2015-09-30 |
$0.01B |
$0.16B |
0.05 |
2015-06-30 |
$0.01B |
$0.04B |
0.18 |
2015-03-31 |
$0.01B |
$0.05B |
0.10 |
2014-12-31 |
$0.00B |
$0.05B |
0.06 |
2014-09-30 |
$0.00B |
|
0.00 |
2014-06-30 |
$0.00B |
|
0.00 |
2014-03-31 |
$0.00B |
|
0.00 |